X-LINKED RETINITIS PIGMENTOSA
Clinical trials for X-LINKED RETINITIS PIGMENTOSA explained in plain language.
Never miss a new study
Get alerted when new X-LINKED RETINITIS PIGMENTOSA trials appear
Sign up with your email to follow new studies for X-LINKED RETINITIS PIGMENTOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene injection aims to halt blindness in rare eye disease
Disease control CompletedThis study tested a one-time gene therapy injection for people with X-linked retinitis pigmentosa (XLRP), a genetic condition that damages the retina and leads to vision loss. The goal was to see if delivering a corrected gene directly into the eye could slow or stop disease prog…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Five-Year watch on Vision-Saving gene therapy
Disease control CompletedThis study followed 42 adults and children for up to 5 years after they received an experimental gene therapy for a genetic eye disease called X-linked retinitis pigmentosa. The main goal was to check for any long-term safety issues from the treatment. Researchers also tracked wh…
Matched conditions: X-LINKED RETINITIS PIGMENTOSA
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC